Medicare ACO Cost Incentives For Part B-To-D Rx Shifts Worry Stakeholders
CMS should look for ways to ensure that financial incentives for Medicare accountable care organizations do not promote inappropriate shifts in prescribing from the Part B benefit to Part D, biotech and clinician groups urge in comments filed with the agency June 6.
You may also be interested in...
In a draft version of its annual instructions to Part D plans, CMS says it is seeking feedback from Part D sponsors and other stakeholders on “possible strategies for achieving better coordination” between stand-alone Medicare Part D plans and accountable care organizations to improve pharmacy care.
Final rule on Medicare accountable care organizations created under the Affordable Care Act is released Oct. 20.
Five divisions include a "seamless" care group to oversee accountable care organizations and similar delivery models.